For individuals exploring peptide therapy options, AOD-9604s documented safety profile provides meaningful information for decision-making discussions with healthcare providers
With respect to dosage, the average reductions were: 2000 mcg: 71.5% (single data point) 1,000 mcg: 31.8% Although limited data are available for higher dosages, the findings support the efficacy of both oral and non-oral B12 formulations in modulating homocysteine levels
Discover how our personalized B12 injections can help you feel rejuvenated, energized, and ready to enjoy life to the fullest
At Liv Hospital, we make sure you get the right vitamin B12 injection dose
The MHRA has not licensed AOD 9604 as a medicinal product in the UK, and its status can be confirmed via the MHRA's product licence search
failed to find the same effect (123), discrepancies which may be explained by technical differences between the studies